Dufner A, Andjelkovic M, Burgering B M, Hemmings B A, Thomas G
Friedrich Miescher Institute, CH-4058 Basel, Switzerland.
Mol Cell Biol. 1999 Jun;19(6):4525-34. doi: 10.1128/MCB.19.6.4525.
Recent studies indicate that phosphatidylinositide-3OH kinase (PI3K)-induced S6 kinase (S6K1) activation is mediated by protein kinase B (PKB). Support for this hypothesis has largely relied on results obtained with highly active, constitutively membrane-localized alleles of wild-type PKB, whose activity is independent of PI3K. Here we set out to examine the importance of PKB signaling in S6K1 activation. In parallel, glycogen synthase kinase 3beta (GSK-3beta) inactivation and eukaryotic translation initiation factor 4E-binding protein 1 (4E-BP1) phosphorylation were monitored as markers of the rapamycin-insensitive and -sensitive branches of the PI3K signaling pathway, respectively. The results demonstrate that two activated PKBalpha mutants, whose basal activity is equivalent to that of insulin-induced wild-type PKB, inhibit GSK-3beta to the same extent as a highly active, constitutively membrane-targeted wild-type PKB allele. However, of these two mutants, only the constitutively membrane-targeted allele of PKB induces S6K1 activation. Furthermore, an interfering mutant of PKB, which blocks insulin-induced PKB activation and GSK-3beta inactivation, has no effect on S6K1 activation. Surprisingly, all the activated PKB mutants, regardless of constitutive membrane localization, induce 4E-BP1 phosphorylation and the interfering PKB mutant blocks insulin-induced 4E-BP1 phosphorylation. The results demonstrate that PKB mediates S6K1 activation only as a function of constitutive membrane localization, whereas the activation of PKB appears both necessary and sufficient to induce 4E-BP1 phosphorylation independently of its intracellular location.
近期研究表明,磷脂酰肌醇-3-羟基激酶(PI3K)诱导的S6激酶(S6K1)激活是由蛋白激酶B(PKB)介导的。对这一假说的支持主要依赖于使用野生型PKB的高活性、组成型膜定位等位基因所获得的结果,其活性独立于PI3K。在此,我们着手研究PKB信号传导在S6K1激活中的重要性。同时,分别监测糖原合酶激酶3β(GSK-3β)失活和真核翻译起始因子4E结合蛋白1(4E-BP1)磷酸化,作为PI3K信号通路中雷帕霉素不敏感和敏感分支的标志物。结果表明,两个激活的PKBα突变体,其基础活性与胰岛素诱导的野生型PKB相当,对GSK-3β的抑制程度与高活性、组成型膜靶向的野生型PKB等位基因相同。然而,在这两个突变体中,只有组成型膜靶向的PKB等位基因诱导S6K1激活。此外,一个干扰性的PKB突变体,它阻断胰岛素诱导的PKB激活和GSK-3β失活,但对S6K1激活没有影响。令人惊讶的是,所有激活的PKB突变体,无论是否组成型膜定位,都诱导4E-BP1磷酸化,而干扰性PKB突变体阻断胰岛素诱导的4E-BP1磷酸化。结果表明,PKB仅作为组成型膜定位的功能介导S6K1激活,而PKB的激活似乎对于诱导4E-BP1磷酸化既是必要的也是充分的,且与其细胞内位置无关。